there are however greater than double the buyers than there are...

there are however greater than double the buyers than there are sellers, so more demand and less supply of shares can only mean one thing for BOT...and without saying rockets...i still mean BOT to the moon. From this week onwards for the next few months will be increases in demand and veeery little supply, all the shares on offer up to $0.50c will be gobbled up in short time with someone splashing couple hundred k like they have been.

Amazing time to be in BOT right now, very low comparatively for this stage of a pharma company with finalised phase 3 trials submitted, the drug itself had no issues with the FDA, only review needed is on the instruction manual. Such low risk for a Blockbuster drug.

And remember, at capturing just 3% of the market, this drug is a Blockbuster ($1B per annum) and this is at 3%, we have THE best drug on offer for hyperhidrosis, so what happens if we capture 10% of the market ($>3B per annum) and our market cap is $300M. Traditionally comapnies in this industry have a market cap of 8x their income...3x8=$24B. Our market cap of $300M looks quite juicy compared to what this will go to once approved over the year once approved...imagine in 2 years when the market is captured.

BOT will overshoot the moon at these prices, my guess is BOT will be the ASX darling for many years to come. Like buying bitcoin in 2005